3 Reasons Why Anthropic IPO Could Be Huge: ETFs in Focus

Anthropic is heading toward a potential blockbuster IPO, fueled by rapid revenue growth, major AI deals and ambitious valuation targets.

Zacks Investment Research • Sep 3, 2026

Barclays' Kristin Peterson on the retail appetite for tech IPOs

Kristin Peterson, Barclays Technology Investment Banking global head, joins 'Squawk on the Street' to discuss the retail appetite for tech IPOs.

CNBC Television • Aug 26, 2026

SpaceX Raised $86 Billion and OpenAI Is Next. This ETF Owns the IPO Class of 2026

The 2026 IPO window blew open this summer. SpaceX's June listing pulled in a reported $86 billion according to Benzinga and other outlets, and Anthropic is now being floated as the next challenger to that record, with OpenAI chatter never far behind.

24/7 Wall Street • Aug 25, 2026

U.S. IPO Market Has More Room to Rally in H2 2026: ETFs Poised to Win

The next phase of the IPO rally could extend beyond tech mega-deals, driven by a more diversified pipeline, benefiting ETFs like FPX and IPO.

Zacks Investment Research • Jul 15, 2026

ETFs in Focus as Anthropic Eyes a Blockbuster IPO

Anthropic's potential IPO could be a blockbuster. Here's how AI and IPO-focused ETFs may benefit from one of the biggest listings in tech.

Zacks Investment Research • Jun 2, 2026

SpaceX IPO Set to Be a Catalyst for 2026 IPO Boom: ETFs to Gain

SpaceX could be the catalyst for a surge as the U.S. IPO market eyes a comeback. ETFs like FPX, IPO and IPOS offer an easy way to gain exposure.

Zacks Investment Research • Apr 2, 2026

U.S. IPO Weekly Recap: REIT Carve-Out Sees Solid Demand While Drone Micro-Cap Soars 500%+

Three IPOs priced this past week, joined by two SPACs, and one major issuer joined the pipeline. One IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for one company in the week ahead, and three lock-up periods will be expiring.

Seeking Alpha • Mar 21, 2026

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

The Fund rebounded and outperformed the Russell 2000 ® Growth Index in the fourth quarter. Boot Barn's revenues and earnings handily exceeded estimates, with greater transaction volumes and new store openings. Abivax reported strong clinical trial results for its obefazimod treatment to address ulcerative colitis in a longer lasting manner.

Seeking Alpha • Mar 18, 2026

AI-Induced Tech Selloff Spoils the IPO Parade

This year was supposed to be a blockbuster for tech offerings of all sizes.

WSJ • Feb 24, 2026

Chart Of The Day: With Past IPOs Slumping, Will Mega-Deals Proceed?

This could be the year of the mega-IPO - with top Artificial Intelligence (AI) companies and SpaceX eyeing 2026 public market debuts. But the performance of past IPOs is souring, raising questions about investor enthusiasm for big deals. The MoneyShow Chart of the Day shows the performance of the Renaissance IPO Index and the S&P 500 Index over the past year. The IPO index generally tracked, or even outperformed, the S&P until September. But it has notably underperformed since then.

Seeking Alpha • Feb 16, 2026